Bexotegrast for treatment of idiopathic pulmonary fibrosis (BEACON-IPF): study protocol for a multinational, phase 2b/3, double-blind, randomised, multicentre, controlled trial

Publication: BMJ Open Respiratory Research
UBC Author(s): Christopher Ryerson (Division of Respiratory Medicine / Faculty of Medicine)
Volume: 13
Publication Date: 10 March 2026